Trius Therapeutics (TSRX)

7.75 -0.02  -0.26%  May 22, 10:53AM
Add to Watchlists Create an Alert

Trius Therapeutics Current Ratio:

5.054 for Dec. 31, 2012
View Full Chart

Trius Therapeutics Current Ratio Chart

    Trius Therapeutics Historical Current Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 5.054
    Dec. 31, 2012 4.002
    Sept. 30, 2012 4.169
    June 30, 2012 5.645
    March 31, 2012 6.998
    Dec. 31, 2011 3.657
    Sept. 30, 2011 4.863
    June 30, 2011 9.757
    March 31, 2011 8.158
       
    Dec. 31, 2010 12.75
    Sept. 30, 2010 17.15
    June 30, 2010 0.5768
    March 31, 2010 6.385
    Dec. 31, 2009 12.41
    Sept. 30, 2009 3.876
    June 30, 2009
    March 31, 2009
    Dec. 31, 2008 10.04

    About Current Ratio

    The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.

    A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.

    Other similar solvency ratios include :
    Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
    Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
    Learn More

    Get data for

    TSRX Current Ratio Benchmarks

    Companies
    Genomic Health 5.467
    Acorda Therapeutics 4.083
    Chembio Diagnostics 3.259

    TSRX Current Ratio Rankings

    Overall 89th percentile
    801 of 8005
    Sector 74th percentile
    176 of 686 in Healthcare
    Industry 78th percentile
    14 of 65 in Diagnostics & Research

    TSRX Current Ratio Range, Past 5 Years

    Minimum 0.5768 Jun 2010
    Maximum 17.15 Sep 2010
    Average 7.219